| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/22/2011 | US20110231942 Tiki1 and tiki2, wnt inhibitors |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230536 Phenylpyrazole inhibitors of store operated calcium release |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230495 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230487 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | US20110230482 Compounds modulating c-fms and/or c-kit activity |
| 09/22/2011 | US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 09/22/2011 | US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 09/22/2011 | US20110230468 Fused heterocyclic compounds and uses thereof |
| 09/22/2011 | US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof |
| 09/22/2011 | US20110230454 (aza)indole derivative and use thereof for medical purposes |
| 09/22/2011 | US20110230452 Compounds and methods for the treatment of pain and other diseases |
| 09/22/2011 | US20110230449 Alkoxylated Phosphoric Acid Triesters With A High Degree Of Alkoxylation |
| 09/22/2011 | US20110230447 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230443 IMIDAZO[1,2-a] PYRIDINYL BISPHOSPHONATES |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230413 Predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| 09/22/2011 | US20110230406 Affinity peptides toward bmp-2 |
| 09/22/2011 | US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229583 Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid |
| 09/22/2011 | US20110229577 Biologically active silicic acid |
| 09/22/2011 | US20110229570 Orally rapidly disintegrating tablet and process for producing same |
| 09/22/2011 | US20110229547 Process for producing inorganic interconnected 3d open cell bone substitutes |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229465 Composition for treating disease |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229457 Injectable drug delivery system |
| 09/22/2011 | US20110229451 Temperature sensitive mutants of matrix metalloproteases and uses thereof |
| 09/22/2011 | US20110229445 Method for healing bone fracture using transfected chondrocytes |
| 09/22/2011 | US20110229440 Differentiation of Human Embryonic and Induced Pluripotent Stem Cells |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110226650 Antibody formulation |
| 09/22/2011 | CA2792927A1 Proteoglycan-containing microneedle array |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366715A2 Rankl Antibody-PTH/PTHRP Chimeric Molecules |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366395A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 09/21/2011 | EP2366391A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366390A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365955A1 Aryl di-substituted propenone compounds |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP1751171B1 Novel galactoside inhibitors of galectins |
| 09/21/2011 | EP1633345B1 Compounds inhibiting the binding of sap for treating osteoarthritis |
| 09/21/2011 | EP1560588B1 Treatment for traumatic synovitis and damaged articular cartilage |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects |
| 09/21/2011 | CN1931318B Chines medicine composition for treating children rickets and other acalcicosis symptoms and its prepn process |
| 09/21/2011 | CN1923263B Traditional Chinese medicine composition, its preparing method and quality controlling means |
| 09/21/2011 | CN1718735B Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 09/21/2011 | CN102196810A Pharmaceutical composition improved in absorption through intestinal tract |
| 09/21/2011 | CN102190728A Novel humanized anti-CD20 monoclonal antibody |
| 09/21/2011 | CN102190719A Polyethylene glycol modified calcitonin |
| 09/21/2011 | CN102190684A Phosphorus-containing compound having drug actions, and preparation and application thereof |
| 09/21/2011 | CN102188758A Preparation method for solid implantation catgut for treating spinal diseases |
| 09/21/2011 | CN102188692A Bone peptide composition, preparation thereof, preparation method thereof and application |
| 09/21/2011 | CN102188688A Traditional Chinese medicine capable of treating cervical and lumbar vertebra hyperosteogeny |
| 09/21/2011 | CN102188686A Traditional Chinese medicine for treating rheumatism and its preparation method |
| 09/21/2011 | CN102188676A Chinese medicine wine for treating hyperosteogeny |
| 09/21/2011 | CN102188673A Plaster for promoting muscles and bones, and preparation and application thereof |
| 09/21/2011 | CN102188668A Chinese medicinal preparation for lumbar vertebra osteoproliferation |
| 09/21/2011 | CN102188661A Traditional Chinese medicine for removing arthralgia and preparation method thereof |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188643A Medicament for treating damp-heat blockage syndrome and its preparation method |
| 09/21/2011 | CN102188634A Chinese medicine composition for treating hyperuricemia |
| 09/21/2011 | CN102188623A Liquid plaster for treating osseous rheumatism and preparation method thereof |
| 09/21/2011 | CN102188621A Application of total dendrobium crepidatum alkaloids in preparing medicament for treating acute and chronic inflammation, acute and chronic arthritis or rheumatoid arthritis diseases |
| 09/21/2011 | CN102188595A Chinese medicine composition for treating arthritis and preparation method thereof |
| 09/21/2011 | CN102188582A Medicinal needle column for treating rheumatic arthralgia |
| 09/21/2011 | CN102188579A Traditional Chinese medicine for treating bone fracture |
| 09/21/2011 | CN102188577A Oral medicine for curing fractures |
| 09/21/2011 | CN102188576A Plaster for the treatment of femur head necrosis |
| 09/21/2011 | CN102188572A Traditional Chinese drug for treating bone trauma |
| 09/21/2011 | CN102188571A Medicament for treating gout |
| 09/21/2011 | CN102188569A Gout health care wine |
| 09/21/2011 | CN102188557A Application of Juncus effuses L. extract in preparing anti-tumor or angiogenesis-inhibiting medicament, health food or cosmetic |
| 09/21/2011 | CN102188555A Health-care wine for treating rheumatism |
| 09/21/2011 | CN102188553A Medicinal wine for oral and external administration and manufacturing method thereof |
| 09/21/2011 | CN102188550A Topical preparation for treating tendon and bone injuries |
| 09/21/2011 | CN102188540A External liniment for treating cervical vertebra and lumbar vertebra diseases |
| 09/21/2011 | CN102188538A Chinese medicine for treating hyperosteogeny of cervical vertebra and lumbar vertebrae |
| 09/21/2011 | CN102188535A Chinese medicine preparation for nourishing blood and promoting blood circulation and preparation method thereof |
| 09/21/2011 | CN102188527A Chinese medicinal skin externally-stuck bone setting medicament |